Cytogenetic remissions induced by interferon α and imatinib mesylate are immunologically distinct in chronic myeloid leukemia
- Author
- NAKAYAMA, Shin1 2 ; NAGAMURA-INOUE, Tokiko2 ; YOKOYAMA, Kazuaki1 2 ; OHNO, Nobuhiro1 ; OOI, Jun1 ; TAKAHASHI, Satoshi1 ; UCHIMARU, Kaoru1 ; ISEKI, Toru1 3 ; TOJO, Arinobu1 2
[1] Department of Hematology/Oncology, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan
[2] Department of Cell Processing and Transfusion, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan
[3] Department of Blood Transfusion, Chiba University School of Medicine, Chiba, Japan - Source
International journal of hematology. 2007, Vol 86, Num 3, pp 208-211, 4 p ; ref : 18 ref
- ISSN
- 0925-5710
- Scientific domain
- Hematology
- Publisher
- Springer, Tokyo
- Publication country
- Japan
- Document type
- Article
- Language
- English
- Author keyword
- CML Cytogenetic remission Imatinib mesylate Interferon α
- Keyword (fr)
- Anticancéreux Cytogénétique Hématologie Imatinib Interféron alpha Rémission Inhibiteur de la tyrosine kinase Leucémie myéloïde chronique STI 571 Enzyme Hémopathie maligne Inhibiteur enzyme Myéloprolifératif syndrome Protein-tyrosine kinase Transferases
- Keyword (en)
- Antineoplastic agent Cytogenetics Hematology Imatinib Alpha interferon Remission Chronic myelogenous leukemia Enzyme Malignant hemopathy Enzyme inhibitor Myeloproliferative syndrome Protein-tyrosine kinase Transferases
- Keyword (es)
- Anticanceroso Citogenética Hematología Imatinib Interferón alfa Remisión Leucemia mieloidea crónica Enzima Hemopatía maligna Inhibidor enzima Mieloproliferativo síndrome Protein-tyrosine kinase Transferases
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19241720
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1532/IJH97.07099 
https://dx.doi.org/10.1532/IJH97.07099
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"International journal of hematology\";s:9:\"\u0000*\u0000stitle\";s:15:\"Int. j. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"208\";s:8:\"\u0000*\u0000epage\";s:3:\"211\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0925-5710\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NAKAYAMA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Shin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:22:\"NAGAMURA-INOUE, Tokiko\";i:1;s:17:\"YOKOYAMA, Kazuaki\";i:2;s:14:\"OHNO, Nobuhiro\";i:3;s:8:\"OOI, Jun\";i:4;s:18:\"TAKAHASHI, Satoshi\";i:5;s:15:\"UCHIMARU, Kaoru\";i:6;s:11:\"ISEKI, Toru\";i:7;s:13:\"TOJO, Arinobu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"International journal of hematology\";s:9:\"\u0000*\u0000stitle\";s:15:\"Int. j. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"208\";s:8:\"\u0000*\u0000epage\";s:3:\"211\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0925-5710\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NAKAYAMA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Shin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:22:\"NAGAMURA-INOUE, Tokiko\";i:1;s:17:\"YOKOYAMA, Kazuaki\";i:2;s:14:\"OHNO, Nobuhiro\";i:3;s:8:\"OOI, Jun\";i:4;s:18:\"TAKAHASHI, Satoshi\";i:5;s:15:\"UCHIMARU, Kaoru\";i:6;s:11:\"ISEKI, Toru\";i:7;s:13:\"TOJO, Arinobu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"International journal of hematology\";s:9:\"\u0000*\u0000stitle\";s:15:\"Int. j. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"208\";s:8:\"\u0000*\u0000epage\";s:3:\"211\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0925-5710\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NAKAYAMA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Shin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:22:\"NAGAMURA-INOUE, Tokiko\";i:1;s:17:\"YOKOYAMA, Kazuaki\";i:2;s:14:\"OHNO, Nobuhiro\";i:3;s:8:\"OOI, Jun\";i:4;s:18:\"TAKAHASHI, Satoshi\";i:5;s:15:\"UCHIMARU, Kaoru\";i:6;s:11:\"ISEKI, Toru\";i:7;s:13:\"TOJO, Arinobu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"International journal of hematology\";s:9:\"\u0000*\u0000stitle\";s:15:\"Int. j. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"208\";s:8:\"\u0000*\u0000epage\";s:3:\"211\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0925-5710\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NAKAYAMA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Shin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:22:\"NAGAMURA-INOUE, Tokiko\";i:1;s:17:\"YOKOYAMA, Kazuaki\";i:2;s:14:\"OHNO, Nobuhiro\";i:3;s:8:\"OOI, Jun\";i:4;s:18:\"TAKAHASHI, Satoshi\";i:5;s:15:\"UCHIMARU, Kaoru\";i:6;s:11:\"ISEKI, Toru\";i:7;s:13:\"TOJO, Arinobu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:19:\"10.1532\/IJH97.07099\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:9:\"\u0000*\u0000jtitle\";s:35:\"International journal of hematology\";s:9:\"\u0000*\u0000stitle\";s:15:\"Int. j. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"86\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"208\";s:8:\"\u0000*\u0000epage\";s:3:\"211\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0925-5710\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"NAKAYAMA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"Shin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:22:\"NAGAMURA-INOUE, Tokiko\";i:1;s:17:\"YOKOYAMA, Kazuaki\";i:2;s:14:\"OHNO, Nobuhiro\";i:3;s:8:\"OOI, Jun\";i:4;s:18:\"TAKAHASHI, Satoshi\";i:5;s:15:\"UCHIMARU, Kaoru\";i:6;s:11:\"ISEKI, Toru\";i:7;s:13:\"TOJO, Arinobu\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:126:\"Cytogenetic remissions induced by interferon \u03b1 and imatinib mesylate are immunologically distinct in chronic myeloid leukemia\";s:8:\"\u0000*\u0000place\";s:5:\"Tokyo\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"4\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
